Showing 631-640 of 9340 results for "".
DermWireTV: Qwo Approved, Assessing Resident Anxiety
https://practicaldermatology.com/videos/dermwire-tv/dermwiretv-qwo-approved-assessing-resident-anxiety/19830/FDA has approved Qwo (collagenase clostridium histolyticum-aaes) from Endo, the first injectable treatment approved for moderate to severe cellulite in the buttocks of adult women. A recent survey offers perspective on anxiety among third-year dermatology residents in light of the COVID crisis. AlleDermWireTV: Meet Crown Aesthetics, Revance to Market Teoxane Fillers, Almirall Collaborates
https://practicaldermatology.com/videos/dermwire-tv/dermwiretv-meet-crown-aesthetics-revance-to-market-teoxane-fillers-almirall-collaborates/19719/On the heels of recent acquisitions, Crown Laboratories is reorganizing and rebranding as three divisions: Crown Aesthetics, Crown Beauty, and Crown Therapeutics. Revance gains immediate and exclusive rights to commercialize Teoxane’s RHA 2, RHA 3, and RHA 4 products, which include lidocaine.DermWireTV: Allē Launches; Arazlo Cleared; BTL Files Suit
https://practicaldermatology.com/videos/dermwire-tv/dermwiretv-alle-launches-arazlo-cleared-btl-files-suit/19714/More than 10 Years and 6 million members later, the Brilliant Distinctions program is being relaunched with a new name and a new app: Allē. Arazlo Lotion 0.045%, the first lotion formulation of tazarotene, is now FDA approved for the topical treatment of acne vulgaris in patients nine years ofDermWireTV: Cosmetic Surgery Forum Highlights, LEO Focuses on AD
https://practicaldermatology.com/videos/dermwire-tv/dermwiretv-cosmetic-surgery-forum-highlights-leo-focuses-on-ad/19703/New treatments and medical controversies take center stage at Cosmetic Surgery Forum as the meeting moves to Nashville in its 11th Year. Leo Pharma’s tralokinumab meets all primary and secondary endpoints in three pivotal Phase 3 studies for the treatment of adults with moderate-to-severe atopAsk an Expert: What's the Role for Infliximab in HS?
https://practicaldermatology.com/topics/general-topics/ask-an-expert-whats-the-role-for-infliximab-in-hs/19671/Evidence shows that infliximab, with its weight-based dosing, can be effective for hidradenitis suppurative. Steven Cohen, MD discusses the data and practical considerations with host Adam Friedman, MD.Food and Atopic Dermatitis
https://practicaldermatology.com/topics/atopic-dermatitis/food-and-atopic-dermatitis/19644/Many patients believe certain foods can exacerbate AD. Peter Lio, MD discusses the potential link.The Risk of Violence Against Physicians
https://practicaldermatology.com/topics/practice-management/the-risk-of-violence-against-physicians/19641/Violence against healthcare workers is a real and growing risk. Kathleen J. Hectorne, MD outlines the problem and ways to de-escalate an encounter.Annual Meeting Highlights; Ortho Derm's New Cash Pay Model
https://practicaldermatology.com/videos/dermwire-tv/dermwire-tv-annual-meeting-highlights-ortho-derm-s-new-cash-pay-model/19579/The annual meeting of the American Academy of Dermatology features updates in medical, surgical, and cosmetic dermatology. Practical Dermatology Chief medical editor Dr. Neal Bhatia highlighted the breadth of coverage at the meeting. DermTube caught up with multiple presenters who shared pearls fromBrightGuard Covers NYC, Galderma Uncovers Rosacea Burden, Dermira's Qbrexza Approved
https://practicaldermatology.com/videos/dermwire-tv/dermwire-tv-brightguard-covers-nyc-galderma-uncovers-rosacea-burden-dermira-s-qbrexza-approved/18288/BrightGuard dispensers have now been installed at 53 public pools and 11 beaches in various locations throughout metropolitan New York. The impact of rosacea can be significant for affected patients. According to survey results released last month by Galderma, 86% of patients with rosacea modify theCash Savings Alternative: Increase Returns & Maintain Liquidity
https://practicaldermatology.com/topics/practice-management/cash-savings-alternative-increase-returns-maintain-liquidity--wnhimepo/18366/OJM Group Director of Financial Advisors Michael Lewellen, CFP provides an overview and financial example of a cash savings alternative that offers 100% liquidity while providing a higher return than traditional investment vehicles. Click here to request or download a free copy of Wealth Protection